secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2023-12-26T23:59:59+00:00
Accession:  0000950170-23-072832
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker agrees to acquire ELITechGroup for €870M enterprise value; Q2 2024 close expected
--------------------------------------------------------------------------------

- Enterprise Value of €870 million; cash purchase price with cash on hand.
- Target projected 2023 revenue of €150M, majority recurring; accretive to non-GAAP EPS in FY2024.
- Put option exercisable after French and Dutch works council consultations; 12-month exclusivity.
- Bruker provided equity commitment letter and secured W&I insurance for seller reps.
- Acquisition is subject to regulatory approvals and carve-out of clinical chemistry business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000095017023072832/0000950170-23-072832-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000095017023072832/brkr-20231226.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-072832

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer